| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/04/2007 | WO2006039343A3 Emmprin antagonists and uses thereof |
| 01/04/2007 | WO2005108622A3 Methods and kits to increase the efficiency of oligonucleotide-directed nucleic acid sequence alteration |
| 01/04/2007 | WO2005033275A3 Methods for altering hematopoietic progenitor cell adhesion, differentiation, and migration |
| 01/04/2007 | WO2005028634A3 Improved mva vaccines |
| 01/04/2007 | US20070006351 Method for regenerating and transforming St. Augustinegrass from embryogenic callus |
| 01/04/2007 | US20070006348 Environmental stress responsive promoter |
| 01/04/2007 | US20070006347 Method for the stable expression of nucleic acids in transgenic plants, controlled by a parsley-ubiquitin promoter |
| 01/04/2007 | US20070006346 Nucleotide sequences and corresponding polypeptides conferring modulated plant growth rate and biomass in plants |
| 01/04/2007 | US20070006345 using nucleic acid molecules to confer the trait of modulated plant size, vegetative growth, organ number, plant architecture, growth rate, seedling vigor, growth rate, fruit and seed yield, tillering and/or biomass in plants |
| 01/04/2007 | US20070006344 Regulatory sequences for expressing gene products in plant reproductive tissue |
| 01/04/2007 | US20070006343 Modified oleosins |
| 01/04/2007 | US20070006342 Lettuce Variety |
| 01/04/2007 | US20070006341 Isolated polypeptide; a disease- or pest-resistance conferring protein |
| 01/04/2007 | US20070006339 Plant caffeic acid 3-O-methyltransferase homologs |
| 01/04/2007 | US20070006337 Nucleic acid and recombinant DNA construct in which the nucleic acid is operably linked to a heterologous nucleic acid; used to modulate transcript levels; transgenic plants |
| 01/04/2007 | US20070006336 Brassica INDEHISCENT1 sequences |
| 01/04/2007 | US20070006335 Promoter, promoter control elements, and combinations, and uses thereof |
| 01/04/2007 | US20070006334 Transgenic animals expressing salivary proteins |
| 01/04/2007 | US20070005148 Method for using tropoelastin and for producing tropoelastin biomaterials |
| 01/04/2007 | US20070005138 grafts composed of two bone anchors joined by matrix layers and/or filaments coated by supplementary biocompatible matrix coating layer which can contain living stem cells isolated from injured tissues |
| 01/04/2007 | US20070004913 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
| 01/04/2007 | US20070004042 Compositions and methods for helper-free production of recombinant adeno-associated viruses |
| 01/04/2007 | US20070004039 Immortalized hepatocytes |
| 01/04/2007 | US20070004038 Preprimitive streak and mesendoderm cells |
| 01/04/2007 | US20070004037 Methods and compositions for culturing keratinocytes |
| 01/04/2007 | US20070004036 Methods and compositions for keratinocyte culture |
| 01/04/2007 | US20070004035 Gene therapy methods and cell growth and cell transplant devices for use therein |
| 01/04/2007 | US20070004034 Process for coating cell-culture support |
| 01/04/2007 | US20070004015 Novel metabolism-associated gene products from ashbya gossypii |
| 01/04/2007 | US20070004012 Reacting chondroitin disaccharide with a recombinantly produced 2-O sulfatase; using 2-O sulfatase for degrading and analyzing glycosaminoglycans (GAGs) present in a sample |
| 01/04/2007 | US20070004009 Methods for making recombinant proteins using apoptosis inhibitors |
| 01/04/2007 | US20070004008 Human ccv polypeptides |
| 01/04/2007 | US20070004005 Tendon-inducing compositions |
| 01/04/2007 | US20070004004 comprising a nucleotide sequence of a mutated TipA gene promoter is capable of thiostrepton-independent and constitutive expression of a gene located downstream |
| 01/04/2007 | US20070003991 Method of diagnosing Lawsonia intracellularis |
| 01/04/2007 | US20070003990 Novel genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer |
| 01/04/2007 | US20070003986 Methods for identifying compounds for treating diabetes mellitus |
| 01/04/2007 | US20070003971 Determining the identity of biallelic markers at a particular position of a FLAP gene and using that information to evaluate whether an individual is at increased risk of asthma |
| 01/04/2007 | US20070003963 RNA sequence-specific mediators of RNA interference |
| 01/04/2007 | US20070003962 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response |
| 01/04/2007 | US20070003961 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response |
| 01/04/2007 | US20070003960 Producing knockdown cells; Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response |
| 01/04/2007 | US20070003951 Determining the replicative history of lymphocytes |
| 01/04/2007 | US20070003946 Use of biomarkers in screening for insulin resistance |
| 01/04/2007 | US20070003929 Method for identifying, analyzing and/or cloning nucleic acid isoforms |
| 01/04/2007 | US20070003594 Tissue engineering scaffold |
| 01/04/2007 | US20070003578 Chimeric protein comprising non-toxic pseudomonas exotoxin and type IV pilin sequences |
| 01/04/2007 | US20070003566 Polyepitope carrier protein |
| 01/04/2007 | US20070003560 Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 01/04/2007 | US20070003553 Anticoagulant agents useful in treatment of thrombosis |
| 01/04/2007 | US20070003548 Anti-TNF antibodies, compositions, methods and uses |
| 01/04/2007 | US20070003545 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 01/04/2007 | US20070003540 Stem cells having increased sensitivity to sdf-1 and methods of generating and using same |
| 01/04/2007 | US20070003533 Inhibition of the beta3 subunit of L-type Ca2+ channels |
| 01/04/2007 | US20070003532 Novel mechanism for identifying drugs for the treatment of type II diabetes |
| 01/04/2007 | US20070003530 Cardiac muscle regeneration using mesenchymal stem cells |
| 01/04/2007 | US20070003529 Generating teeth from bone marrow cells |
| 01/04/2007 | US20070003528 Intracoronary device and method of use thereof |
| 01/04/2007 | US20070003526 Blood vessel-specific organogenesis from embryonic stem cells on three-dimensional matrigel layer |
| 01/04/2007 | US20070003524 Targeted retrograde gene delivery to motor neurons |
| 01/04/2007 | US20070003515 Method of inducing memory b cell development and terminal differentiation |
| 01/04/2007 | DE102005031532A1 Lagermedium für Zellen Storage medium for cells |
| 01/04/2007 | CA2818182A1 Methods and compositions for enhancing vascular access |
| 01/04/2007 | CA2620567A1 Cardiomyocyte cell populations |
| 01/04/2007 | CA2617222A1 Peptide derived from prostate-related protein as cancer vaccine candidate for prostate cancer patient who is positive for hla-a3 super-type allele molecule |
| 01/04/2007 | CA2613697A1 Components of cell culture media produced from plant cells |
| 01/04/2007 | CA2613529A1 Reporter hepatocytes and other cells for drug screening and toxicity testing |
| 01/04/2007 | CA2613387A1 Mesoderm and definitive endoderm cell populations |
| 01/04/2007 | CA2613369A1 Suspension culture of human embryonic stem cells |
| 01/04/2007 | CA2613284A1 Methods and compositions for expressing negative-sense viral rna in canine cells |
| 01/04/2007 | CA2613008A1 Using cytosine deaminases to diminish retroelement transfer from pigs to humans |
| 01/04/2007 | CA2612760A1 Il-1.beta. binding antibodies and fragments thereof |
| 01/04/2007 | CA2612751A1 Vegf-containing transport media composition for storing cells engrafted in a biocompatible matrix |
| 01/04/2007 | CA2612549A1 Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase |
| 01/04/2007 | CA2612486A1 Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumour cells |
| 01/04/2007 | CA2612465A1 Delivery of active proteins to the central nervous system using phage vectors |
| 01/04/2007 | CA2612188A1 Methods for treating ischemic tissue |
| 01/04/2007 | CA2611809A1 Differentiation of primate pluripotent stem cells to cardiomyocyte-lineage cells |
| 01/04/2007 | CA2610995A1 A device including a proteinaceous factor, a recombinant proteinaceous factor, and a nucleotide sequence encoding the proteinaceous factor |
| 01/04/2007 | CA2609142A1 Therapeutic gene vectors comprising mirna target sequences |
| 01/04/2007 | CA2606292A1 System and process for genetic and epigenetic treatment |
| 01/04/2007 | CA2584803A1 Disimmortalizable mammalian chromaffin cell lines for cell therapy for pain |
| 01/03/2007 | EP1739180A1 T cell line-based packaging cell line for the production of retroviruses by enriching of CD3 expressing cells |
| 01/03/2007 | EP1739179A1 Serum-free stable transfection and production of recombinant human proteins in human cell lines |
| 01/03/2007 | EP1739177A1 Antibodies against interferon alpha/beta receptor |
| 01/03/2007 | EP1739171A1 Novel gene participating in epidermal differentiation and use thereof |
| 01/03/2007 | EP1739167A1 Method of producing virus |
| 01/03/2007 | EP1739166A1 Obtention of food- or auto-antigen specific Tr1 cells from a leukocyte or PBMC population |
| 01/03/2007 | EP1739090A2 Interferon-beta fusion proteins and uses |
| 01/03/2007 | EP1738717A2 In vitro production of transplantable cartilage tissue |
| 01/03/2007 | EP1738253A2 Systems and methods for providing a stem cell bank |
| 01/03/2007 | EP1737974A2 Methods for identifying proteins with starch phosphorylating enzymatic activity |
| 01/03/2007 | EP1737973A1 Truncated adamts molecules |
| 01/03/2007 | EP1737950A2 Cells exhibiting neuronal progenitor cell characteristics |
| 01/03/2007 | EP1737949A2 Endothelial progenitor cells and methods of use thereof |
| 01/03/2007 | EP1737948A2 Methods of promoting cardiac cell proliferation |
| 01/03/2007 | EP1737947A2 Mapc generation of lung tissue |
| 01/03/2007 | EP1737944A2 Methods for generating insulin-producing cells |
| 01/03/2007 | EP1737891A1 Anti-p-selectin antibodies |
| 01/03/2007 | EP1737888A2 Erythropoietin protein variants |